SK17082000A3 - 1,2,5-trisubstituovan 1,2-dihydro-indazol-3-ny s antiastmatickm, antialergickm, protizpalovm, imunomodulanm a neuroprotektvnym inkom, spsob ich prpravy a ich pouitie - Google Patents

1,2,5-trisubstituovan 1,2-dihydro-indazol-3-ny s antiastmatickm, antialergickm, protizpalovm, imunomodulanm a neuroprotektvnym inkom, spsob ich prpravy a ich pouitie Download PDF

Info

Publication number
SK17082000A3
SK17082000A3 SK1708-2000A SK17082000A SK17082000A3 SK 17082000 A3 SK17082000 A3 SK 17082000A3 SK 17082000 A SK17082000 A SK 17082000A SK 17082000 A3 SK17082000 A3 SK 17082000A3
Authority
SK
Slovakia
Prior art keywords
methoxy
indazol
dihydro
alkyl
formula
Prior art date
Application number
SK1708-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Rudolf Schindler
Norbert Hfgen
Hildegard Poppe
Kay Brune
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of SK17082000A3 publication Critical patent/SK17082000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1708-2000A 1998-05-11 1999-04-01 1,2,5-trisubstituovan 1,2-dihydro-indazol-3-ny s antiastmatickm, antialergickm, protizpalovm, imunomodulanm a neuroprotektvnym inkom, spsob ich prpravy a ich pouitie SK17082000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19821003A DE19821003A1 (de) 1998-05-11 1998-05-11 Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/002291 WO1999058504A1 (de) 1998-05-11 1999-04-01 Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver wirkung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
SK17082000A3 true SK17082000A3 (sk) 2001-09-11

Family

ID=7867363

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1708-2000A SK17082000A3 (sk) 1998-05-11 1999-04-01 1,2,5-trisubstituovan 1,2-dihydro-indazol-3-ny s antiastmatickm, antialergickm, protizpalovm, imunomodulanm a neuroprotektvnym inkom, spsob ich prpravy a ich pouitie

Country Status (23)

Country Link
US (1) US6180637B1 (tr)
EP (1) EP1077948A1 (tr)
JP (1) JP2002514627A (tr)
KR (1) KR20010025011A (tr)
CN (1) CN1309642A (tr)
AR (1) AR018605A1 (tr)
AU (1) AU745796B2 (tr)
BG (1) BG104910A (tr)
BR (1) BR9911772A (tr)
CA (1) CA2271837A1 (tr)
CO (1) CO5021131A1 (tr)
DE (1) DE19821003A1 (tr)
HK (1) HK1038751A1 (tr)
HU (1) HUP0101707A3 (tr)
IL (1) IL139358A0 (tr)
NO (1) NO20005698L (tr)
NZ (1) NZ508646A (tr)
PL (1) PL344254A1 (tr)
SK (1) SK17082000A3 (tr)
TR (1) TR200003302T2 (tr)
TW (1) TW448163B (tr)
WO (1) WO1999058504A1 (tr)
ZA (1) ZA200006151B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) * 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
WO2008141385A1 (en) * 2007-05-21 2008-11-27 Biota Scientific Management Pty Ltd Viral polymerase inhibitors
SG193454A1 (en) 2011-03-14 2013-10-30 Boehringer Ingelheim Int Benzodioxane inhibitors of leukotriene production
WO2013012844A1 (en) 2011-07-19 2013-01-24 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
TW201350475A (zh) 2012-03-06 2013-12-16 Boehringer Ingelheim Int 用於組合療法之白三烯素生成之苯并二噁烷抑制劑
US8946203B2 (en) 2012-03-06 2015-02-03 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
JP6256467B2 (ja) 2012-07-17 2018-01-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成を阻害するピラゾール誘導体
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
EP3022193B1 (en) 2013-07-15 2017-04-26 Boehringer Ingelheim International GmbH Inhibitors of leukotriene production
KR20190017873A (ko) * 2016-06-08 2019-02-20 썬리겐 헬쓰케어 아게 홀수의 탄소 원자를 갖는 지질 및 제약 조성물 또는 영양 보충제로서의 그의 용도
CN113105409B (zh) * 2021-04-06 2023-06-02 四川大学 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途
CA3221177A1 (en) 2021-11-01 2023-05-04 Meghan Kerrisk Campbell Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132916A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5179112A (en) * 1985-04-17 1993-01-12 Ici Americas Inc. Heterocyclic amide derivatives and pharmaceutical use
IL84944A (en) * 1987-01-19 1992-02-16 Ici Plc Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
US5036083A (en) * 1988-07-15 1991-07-30 Ici Pharma Heterocyclic agents
US5229408A (en) * 1988-07-15 1993-07-20 Ici Pharma 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives
DE19610882A1 (de) * 1996-03-20 1997-09-25 Dresden Arzneimittel Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
HUP0101707A2 (hu) 2002-03-28
NO20005698D0 (no) 2000-11-10
CO5021131A1 (es) 2001-03-27
ZA200006151B (en) 2000-12-06
NZ508646A (en) 2002-11-26
HUP0101707A3 (en) 2002-06-28
DE19821003A1 (de) 1999-11-18
CA2271837A1 (en) 1999-11-11
JP2002514627A (ja) 2002-05-21
WO1999058504A9 (de) 2000-02-03
AU745796B2 (en) 2002-03-28
TW448163B (en) 2001-08-01
CN1309642A (zh) 2001-08-22
AU4257699A (en) 1999-11-29
BG104910A (en) 2001-06-29
WO1999058504A1 (de) 1999-11-18
PL344254A1 (en) 2001-10-22
IL139358A0 (en) 2001-11-25
BR9911772A (pt) 2001-02-06
NO20005698L (no) 2001-01-08
AR018605A1 (es) 2001-11-28
EP1077948A1 (de) 2001-02-28
HK1038751A1 (zh) 2002-03-28
TR200003302T2 (tr) 2001-02-21
KR20010025011A (ko) 2001-03-26
US6180637B1 (en) 2001-01-30

Similar Documents

Publication Publication Date Title
JP4729259B2 (ja) カリウムチャンネル機能のヘテロ環インヒビター
JP4986853B2 (ja) プロスタグランジンｄ合成酵素を阻害するベンゾイミダゾール化合物
JP5658284B2 (ja) Ｃｒｔｈ２アンタゴニストとしてのピラゾール化合物
SK13082002A3 (sk) Substituované beta-karbolíny, spôsob ich prípravy a farmaceutické prostriedky, ktoré ich obsahujú
JP2003500403A (ja) ｐ３８キナーゼのインヒビターとしてのインドール型誘導体
WO2004045607A1 (de) Neue hydroxyindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung
JPH11513382A (ja) ５員複素環化合物、これらの化合物を含む医薬品、それらの使用及びそれらの調製方法
TW200948800A (en) Organic compounds
EP2004602A1 (en) Salts with crth2 antagonist activity
JP2001514227A (ja) ピラジノン系トロンビン阻害薬
JP2007518776A (ja) キノリン誘導体及びマイコバクテリア抑制剤としてのその使用
SK17082000A3 (sk) 1,2,5-trisubstituovan 1,2-dihydro-indazol-3-ny s antiastmatickm, antialergickm, protizpalovm, imunomodulanm a neuroprotektvnym inkom, spsob ich prpravy a ich pouitie
JP2010502615A (ja) ５−リポキシゲナーゼ活性化タンパク質（ｆｌａｐ）の阻害剤
WO2005099705A2 (en) Preparation of imidazole derivatives and methods of use
US6313116B1 (en) Benzothiazole compounds and their therapeutic use
SK17092000A3 (sk) 1,5- a 3-o-substituované 1h-indazoly s antiastmatickým, antialergickým, protizápalovým, imunomodulačným a neuroprotektívnym účinkom, spôsob ich prípravy a ich použitie ako liekov
CZ20004168A3 (cs) Nové 1,2,5-trisubstituované l,2-dihydroindazol-3- ony s antiastmatickým, antialergickým, protizánětlivým, iinunoniodulačním a neuroprotektivním účinkem, způsob jejich přípravy a jejich použití jako léčiva
CZ20011164A3 (cs) Nové soli pyridopyridazinové sloučeniny a jejich krystaly
MXPA00011060A (en) Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament
CZ20004152A3 (cs) Nové 1,5 a 3-0-substituované ΙΗ-indazoly s antiastmatickým, antialergickým, protizánětlivým, imunomodulačním a neuroprotektivním účinkem, způsob jejich přípravy a jejich použití jako léčiva
MXPA00011058A (en) Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
WO1991000275A1 (en) Butane compounds or salts thereof and their medical uses
WO1998023607A1 (fr) Derives de 1,4-dihydropyridine